Trade Stoke Therapeutics, Inc. - STOK CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.11 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023401% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001179% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 7.52 |
| Open | 7.32 |
| 1-Year Change | -41.2% |
| Day's Range | 7.32 - 7.65 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 17, 2025 | 7.63 | 0.35 | 4.81% | 7.28 | 7.67 | 7.28 |
| Apr 16, 2025 | 7.52 | -0.01 | -0.13% | 7.53 | 7.55 | 7.26 |
| Apr 15, 2025 | 7.71 | 0.39 | 5.33% | 7.32 | 7.91 | 7.28 |
| Apr 14, 2025 | 7.51 | 0.51 | 7.29% | 7.00 | 7.62 | 6.80 |
| Apr 11, 2025 | 6.96 | 0.55 | 8.58% | 6.41 | 7.07 | 6.23 |
| Apr 10, 2025 | 6.48 | 0.37 | 6.06% | 6.11 | 6.50 | 5.87 |
| Apr 9, 2025 | 6.37 | 0.61 | 10.59% | 5.76 | 6.41 | 5.29 |
| Apr 8, 2025 | 5.85 | -0.26 | -4.26% | 6.11 | 6.25 | 5.66 |
| Apr 7, 2025 | 5.94 | 0.23 | 4.03% | 5.71 | 6.09 | 5.40 |
| Apr 4, 2025 | 5.88 | -0.04 | -0.68% | 5.92 | 6.08 | 5.60 |
| Apr 3, 2025 | 6.26 | 0.19 | 3.13% | 6.07 | 6.33 | 5.95 |
| Apr 2, 2025 | 6.54 | 0.43 | 7.04% | 6.11 | 6.60 | 5.96 |
| Apr 1, 2025 | 6.18 | -0.28 | -4.33% | 6.46 | 6.65 | 6.05 |
| Mar 31, 2025 | 6.59 | -0.34 | -4.91% | 6.93 | 6.98 | 6.55 |
| Mar 28, 2025 | 7.16 | -0.20 | -2.72% | 7.36 | 7.43 | 7.01 |
| Mar 27, 2025 | 7.39 | 0.13 | 1.79% | 7.26 | 7.46 | 7.26 |
| Mar 26, 2025 | 7.35 | -0.26 | -3.42% | 7.61 | 7.61 | 7.08 |
| Mar 25, 2025 | 7.70 | -0.39 | -4.82% | 8.09 | 8.20 | 7.46 |
| Mar 24, 2025 | 8.23 | 0.12 | 1.48% | 8.11 | 8.38 | 8.06 |
| Mar 21, 2025 | 8.10 | 0.06 | 0.75% | 8.04 | 8.25 | 7.62 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Stoke Therapeutics, Inc. Company profile
About Stoke Therapeutics Inc
Stoke Therapeutics, Inc. is a biotechnology company. It focuses to treat the underlying causes of severe genetic diseases by upregulating protein expression. It is developing antisense oligonucleotide (ASO) medicines that target ribonucleic acid (RNA) and modulate precursor-messenger RNA (pre-mRNA) splicing to upregulate protein expression where needed and with appropriate specificity to near normal levels. It focuses to develop the precision medicine platform to target the underlying cause of a spectrum of genetic diseases in which the patient has healthy copy of a gene and mutated copy that fails to produce a protein essential to health. It utilizes its technology platform, Targeted Augmentation of Nuclear Gene Output (TANGO) to design ASOs to upregulate the expression of protein by individual genes in a patient. Its product candidate, STK-001, is offered to treat Dravet syndrome. Its research platform is designed to address protein deficiency.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Stoke Therapeutics Inc revenues was not reported. Net loss increased 64% to $85.8M. Higher net loss reflects Research and development - Balancing val increase of 58% to $48M (expense), Stock-based Compensation in SGA increase from $3.9M to $10.2M (expense), General and administrative - Balancing increase of 28% to $21.7M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
45 Wiggins Avenue
BEDFORD
MASSACHUSETTS 01730
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com